Dr Giovanni Satta began his medical training in Italy before coming to the UK to study at the London School of Hygiene and Tropical Medicine. He then undertook specialist training in both infectious diseases and microbiology and completed the majority of his UK training at the Royal Free Hospital. He was also an academic fellow at University College London (UCL) where he completed a PhD on whole genome sequencing and its applications to new drugs development against Mycobacterium tuberculosis. He also hold a MBA in Healthcare with a thesis on the consolidation of pathology services in England.
He is currently a consultant at Imperial College Healthcare NHS Trust and the Head of Specialty for infection. He has also been awarded a Medical Research Council Clinical Academic Research Partnership (2019-2022) with a specific research interest in drug discovery and next generation sequencing in non-tuberculous Mycobacteria.
Community and hospital acquired infections, surgical infections, chronic infections, multidrug resistance, infection control, expert panel member for NICE, including past diagnostic technologies and SSI guidelines
Research & publications
Dr Satta research interests include new drugs development against Mycobacterium tuberculosis (MTB), non-tuberculous Mycobacteria, whole genome sequencing and new rapid diagnostics.